Irini D Flouri (Irini Flouri)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Ejection Fraction

Disease Activity

Pain Management

Top Venues

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Irini D Flouri, Panagiota Goutakoli, Argyro Repa, Antonios Konstantinos Bertsias, Nestor Avgoustidis, Anastasios Eskitzis, Sofia Pitsigavdaki, Eleni Kalogiannaki, Maria Terizaki, George K Bertsias, Prodromos Sidiropoulos
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study. Rheumatology international (2023)